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Abstract
Objectives
Epilepsy is a relatively common disease in childhood. In some 
patients, the electroencephalogram (EEG) is abnormal despite the 
clinical control of seizures. Studies have identified the adverse effects 
of epileptic discharges on cognition, learning, behavior, and seizure 
recurrence in children. This study investigated the Levetiracetam 
effect on epileptic discharges in the interictal phase of EEG in epileptic 
children.
Materials & Methods
 This clinical trial was conducted on 54 epileptic children aged 2 to 
15 years, whose clinical seizures were controlled by sodium valproate 
in the last six months but still had epileptic discharges in EEG. The 
participants were divided into two groups: an intervention group (21 
people), for which Levetiracetam was added to sodium valproate, and 
a control group (33 people), for which treatment with sodium valproate 
alone was continued. The patients were then followed for one year.
Results
The percent normalization of epileptic discharges in the intervention 
and control groups was 66.7% and 57.1% (P = 0.500), respectively. 
Also, the mean time for the normalization of epileptic discharges in 
the intervention and control groups was 12.60±8.25 and 20.57±12.67 
months (P = 0.042), respectively.
Conclusion
In children with controlled seizures whose EEG was still abnormal, 
sodium valproate therapy alone and combined with Levetiracetam 
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effectively reduced the severity of epileptic discharges. However, the 
addition of Levetiracetam to sodium valproate normalized EEG more 
rapidly.  




Epilepsy is the most common chronic neurological 
disorder in children, with a prevalence of about 1% 
on average (1). The epilepsy prevalence is reported 
to be 3.2-5.5 per 1000 in developed countries and 
3.6-44 per 1000 in underdeveloped countries (2). 
In some of the epileptic children, EEG shows 
epileptic discharges despite the clinical control of 
seizure.
Studies have shown that epileptic discharges in 
children, even in the absence of clinical seizures, 
can be associated with cognitive, verbal, memory, 
and behavioral disorders (3-5). Epileptic discharges 
have been reported in 24% of children with ADHD 
(6). The clinical recurrence of seizures is more 
likely in people with abnormal EEG than in those 
with normal EEG (7). Sodium valproate is a widely 
used anti-epileptic drug with broad-spectrum 
activity that has been the first-line drug for most 
seizure types in children (8). Levetiracetam is also 
one of the new anticonvulsant drugs used to control 
many types of pediatric seizures (9, 10). There 
are some pieces of evidence that Levetiracetam 
can reduce epileptic discharges in the interictal 
phase in epileptic patients (11-13). Kanemura et 
al. (2018), in their study, compared the efficacy 
of carbamazepine and valproate sodium with 
Levetiracetam in reducing rolandic discharges on 
interictal electroencephalogram in children with 
rolandic epilepsy. They showed that Levetiracetam 
was superior to carbamazepine and valproate 
sodium in suppressing discharges in children with 
rolandic epilepsy (11).
In a multicenter, prospective, long-term study, 
Speechio et al. (2008) evaluated the effects of 
Levetiracetam on EEG abnormalities and the 
photoparoxysmal response of patients with 
juvenile myoclonic epilepsy. Efficacy parameters 
were based on comparing and analyzing EEG 
interictal abnormalities classified as spikes and 
waves, polyspikes and waves, and the presence 
of PPR. Levetiracetam effectively decreased 
epileptiform EEG abnormalities and suppressed 
the photoparoxysmal response of patients with 
juvenile myoclonic epilepsy (13).
The use of Levetiracetam also reduces epileptic 
discharges in other non-seizure disorders, such as 
ADHD. This drug has fewer side effects and drug 
interactions than other first-line drugs (14, 15).
 As previously mentioned, epileptic discharges 
in EEG can cause impairment in cognitive and 
behavioral development and increase the risk of 
recurrence in children. Thus, this study aimed 
to investigate the decreasing effect of adding 
Levetiracetam to sodium valproate on epileptic 
discharges in the interictal phase in epileptic 
children who still have abnormal EEG despite the 
clinical control of seizures. 
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Materials & Methods
This clinical trial was conducted on 54 epileptic 
children aged 2 to 15 years admitted to the 
department of pediatric neurology of the Besat 
Hospital, Hamadan, Iran, in 2018. Clinical seizures 
in the patients were controlled by sodium valproate 
in the last six months, but they still had epileptic 
discharges in EEG.
The patients were divided into two groups: an 
interventional group (21 people), for which 
Levetiracetam tablets (manufactured by Cobel 
Company with a dose of 50 mg/kg and blood levels 
above 5 mg/L) were added to sodium valproate 
(manufactured by Rahakin Company with a dose of 
20-30 mg/kg and blood levels above 50 mg/L) and 
a control group (33 people), for which treatment 
with sodium valproate alone was continued.
Then, the patients were monitored for seizure 
recurrence, drug side effects, and EEG changes 
every three months, for a period of one year. 
Periodic CBC and liver function tests were 
performed in both groups.
The patients’ demographic information was 
collected using a checklist.
The inclusion criteria were children aged 2 to 15 
years with idiopathic generalized tonic, clonic, or 
tonic-clonic seizures and tonic or clonic idiopathic 
focal seizures, no clinical seizures in the last six 
months, Spike-Wave epileptic discharges in EEG, 
and sodium valproate consumption for at least six 
months with a 20-30 mg/kg dose and blood levels 
above 50 mg/dl.
The exclusion criteria included the need to 
change the treatment regimen and initiate other 
anticonvulsant drugs and patients not providing 
consent or cooperation to participate in the study.
In children with good cooperation, EEG was 
performed in awake children with eyes open and 
closed for 20 minutes with hyperventilation and 
optical stimulation.
In non-cooperative children, EEG was performed 
for 20 minutes under sedation using chloral hydrate 
syrup.
EEG was recorded using 10-20 methods with 
a 16-channel Ebeneuro device. A pediatric 
neurologist studied all ECGs and determined the 
severity of epileptic seizures.
The severity of epileptic discharges (according to 
the number of epileptic discharges) was divided 
into four groups.
1. Normal
2. Mild: Epileptic discharges in some EEG pages 
(each page contains 10 seconds of EEG recording)
3. Moderate: Epileptic discharges in all EEG pages 
but with a distribution of less than 20% per page
4. Severe: Epileptic discharges in all EEG pages 
with the distribution of epileptic discharges in 
more than 20% of EEG pages
After collecting the data, SPSS software version 
21 was used to analyze the data. Fisher’s exact test 
and the chi-square test were used to evaluate the 
association between the two categorized variables, 
and the Z-score test was used to compare normal 
percent changes between the groups after the 
intervention. Moreover, an independent t-test 
and the Mann-Whitney U test were used to 
compare means concerning normal and un-normal 
measurements distribution, respectively. The 
significance level of the tests was considered less 
than 0.05.
This study was conducted with the approval of 
the Ethics Committee of the Hamadan University 
of Medical Sciences with the ethics code, the 
Deputy of Research and Technology IR.USHA.
REC.1397.146, IRCT20120215009014N246. 
Informed consent was obtained from all the 
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patients or their parents.
Results
There was no significant difference between the 
two groups regarding age, sex, the severity of 
seizures (Tables 1 and 2). EEG normalization 
became normal in 15 (71.4%) of patients in the 
intervention group and 21 (63.16%) of patients in 
the control group. However, the frequency of EEG 
normalization was higher in the intervention group 
than in the control group, although not statistically 
significant (P = 0.554).
In both groups, the severity of epileptic discharges 
significantly decreased after the treatment 
compared to before the treatment (P< 0.001). 
Table 1. Distribution of demographic and clinical characteristics between two groups















However, the severity of EEG abnormalities did 
not show a statistically significant difference 
(Table 2) between the two groups before and after 
the treatment. The recurrence of clinical seizures 
occurred in seven (21.2%) of patients in the control 
group and two (9.5%) of patients in the intervention 
group (P = 0.256).
The mean time for normalization of the first EEG 
was 12.608.25± and 20.5712.67  ± months (P = 
0.042) in the intervention and control groups, 
respectively. Moreover, no significant drug side 
effects leading to discontinuation of the treatment 
were observed in either group.
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Discussion
This study showed that the patients’ EEG 
was normalized in a shorter period by adding 
Levetiracetam to sodium valproate. Moreover, the 
number of cases with normalized EEG was higher 
in the intervention group, although not significant. 
This may be due to the small number of people 
under study.
Our study showed that sodium valproate therapy 
alone and in combination with Levetiracetam 
effectively corrected epileptic discharges in EEG. 
However, the addition of Levetiracetam to sodium 
valproate did not significantly alter the effect of 
sodium valproate alone on EEG.
Previous studies have shown that sodium valproate 
is effective in correcting EEG (5, 8). Kanemura 
et al. and Wang et al., in their studies showed the 
Levetiracetam efficacy in correcting epileptic 
discharges in EEG (11,12), although Levetiracetam 
was not effective in Stodieck et al.’s study (16). 
Numerous studies have shown that epileptic 
discharges in children, even in the absence of clinical 
seizures, can be associated with cognitive, verbal, 
memory, and behavioral disorders (3). Previous 
studies have also shown that anticonvulsant drug 
therapy in children with developmental disorders 
that have abnormal EEG without clinical seizures 
improves the course of development (4, 5, 17). In 
Liu Z et al.’s study, Levetiracetam combined with 
sodium valproate produced better efficacy and 
fewer adverse reactions, significantly improved 
patients’ quality of life and cognitive function, 
and notably lowered the content of neurological 
function indicators with notable EEG improvement 
(18).
Also, in children with behavioral disorders and 
ADHD who have abnormal EEG without clinical 
seizures, the correction of EEG has been effective 
in improving behavioral disorders (6).
Although in our study, adding Levetiracetam to 
sodium valproate did not significantly increase the 
extent of recovery, it shortened the meantime for 
EEG normalization by about eight months.
In Conclusion
Adding Levetiracetam to sodium valproate in 
children with idiopathic epilepsy, who have 
Table 2. Severity of interictal epileptic discharges in EEG before and after treatment in two groups
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abnormal EEG despite controlling clinical seizures, 
shortens the time to achieve normal EEG. 
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